Journal of Clinical Oncology, Vol 14, 2431-2434, Copyright © 1996 by American Society of Clinical Oncology

ARTICLES

Image-guided core-needle biopsy in malignant lymphoma: experience with 100 patients that suggests the technique is reliable

D Ben-Yehuda, A Polliack, E Okon, Y Sherman, S Fields, P Lebenshart, H Lotan and E Libson
Department of Hematology, Hadassah University Hospital, Jerusalem, Israel.

PURPOSE: In an initial evaluation of 1,500 computed tomography (CT)- guided core-needle biopsies performed at our institute during the period from 1989 to 1994, we encountered 100 patients with the diagnosis of lymphoma. Here, we review the clinical impact of 109 image- guided needle biopsies in these 100 patients with non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD). PATIENTS AND METHODS: NHL was diagnosed in 71 patients, and 29 had HD. Among the NHL patients, 17 (24%) had proven lymphoma diagnosed before the biopsy was performed; in 54 (76%) core-needle biopsy was performed as the first diagnostic procedure. Of 29 HD patients, nine (31%) were already established cases of HD, and in 20 (69%) core-needle biopsy was the first diagnostic procedure attempted. Most of the biopsies were performed under CT control using a 20- or 18-gauge Turner biopsy needle. RESULTS: Eighty- six patients received therapy based on the results of the needle biopsy alone. Fourteen patients received therapy after undergoing surgical biopsy for a suspected diagnosis of lymphoma, which could not be established with certainty on the basis of an earlier core-needle biopsy alone. In 78% of the patients, the needle biopsy saved a further surgical procedure that may have been difficult to perform because of the primary location of the tumor. CONCLUSION: From our experience in this study, image-guided core-needle biopsies provide sufficient information for the diagnosis of and subsequent therapeutic decision to treat most cases of lymphoma.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Soudack, R. B. Shalom, O. Israel, Y. Ben-Arie, Z. Levy, and D. Gaitini Utility of Sonographically Guided Biopsy in Metabolically Suspected Recurrent Lymphoma J. Ultrasound Med., February 1, 2008; 27(2): 225 - 231. [Abstract] [Full Text] [PDF]

				O. Asoglu, L. Porter, J. H. Donohue, and S. S. Cha Laparoscopy for the Definitive Diagnosis of Intra-abdominal Lymphoma Mayo Clin. Proc., May 1, 2005; 80(5): 625 - 631. [Abstract] [PDF]

				S. Lieberman, E. Libson, B. Maly, P. Lebensart, D. Ben-Yehuda, and A. I. Bloom Imaging-Guided Percutaneous Splenic Biopsy Using a 20- or 22-Gauge Cutting-Edge Core Biopsy Needle for the Diagnosis of Malignant Lymphoma Am. J. Roentgenol., October 1, 2003; 181(4): 1025 - 1027. [Abstract] [Full Text] [PDF]

				N. Goldschmidt, E. Libson, A. Bloom, G. Amir, and O. Paltiel Clinical utility of computed tomography-guided core needle biopsy in the diagnostic re-evaluation of patients with lymphoproliferative disorders and suspected disease progression Ann. Onc., September 1, 2003; 14(9): 1438 - 1441. [Abstract] [Full Text] [PDF]

				E. A. Rendina, F. Venuta, T. De Giacomo, A. M. Ciccone, M. S. Moretti, M. Ibrahim, and G. F. Coloni Biopsy of anterior mediastinal masses under local anesthesia Ann. Thorac. Surg., November 1, 2002; 74(5): 1720 - 1723. [Abstract] [Full Text] [PDF]

				N. J. Screaton, L. H. Berman, and J. W. Grant Head and Neck Lymphadenopathy: Evaluation with US-guided Cutting-Needle Biopsy Radiology, July 1, 2002; 224(1): 75 - 81. [Abstract] [Full Text]

				D. Gossot, P. Girard, Eric de Kerviler, P. Brice, J.-D. Rain, T. Leblanc, and D. Grunenwald Thoracoscopy or CT-Guided Biopsy for Residual Intrathoracic Masses After Treatment of Lymphoma Chest, July 1, 2001; 120(1): 289 - 294. [Abstract] [Full Text] [PDF]

				B. Ghaye and R.F. Dondelinger Imaging guided thoracic interventions Eur. Respir. J., March 1, 2001; 17(3): 507 - 528. [Abstract] [Full Text] [PDF]

				F. Cabanillas, S. Horning, M. Kaminski, and R. Champlin Managing Indolent Lymphomas in Relapse: Working Our Way Through a Plethora of Options Hematology, January 1, 2000; 2000(1): 166 - 179. [Abstract] [Full Text] [PDF]

				B. D. Cheson, S. J. Horning, B. Coiffier, M. A. Shipp, R. I. Fisher, J. M. Connors, T. A. Lister, J. Vose, A. Grillo-Lopez, A. Hagenbeek, et al. Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas J. Clin. Oncol., April 1, 1999; 17(4): 1244 - 1244. [Abstract] [Full Text] [PDF]